HANGZHOU TIGERMED CONSULTING CO LTD
(HKEX: 3347)

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

51.000 -

+3.220 (+6.74%)
Range 47.080 - 51.450   (9.28%)
Open 47.080
Previous Close 47.780
Bid Price 51.000
Bid Volume ('000) 2.2
Ask Price 51.150
Ask Volume ('000) 7.3
Volume ('000) 2,741.8
Value 137,833,732
Remark -
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis